Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5029 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 14 out of 35
341 citations found

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling

Seshadri, S;Allan, DSJ;Carlyle, JR;Zenewicz, LA;

Product: Anthrax Lethal Factor (LF), Recombinant, Mutant E687C from B. anthracis

  • Lethal toxin and signaling inhibitors:

    Recombinant protective antigen and wild-type lethal factor or lethal factor mutant (E687C) were obtained from List Biologicals (Campbell, CA) …

    In vitro lethal toxin assay with Rag1-/- splenocytes or human tonsillar lymphocytes:

    100,000500,000 splenocytes per well were incubated in a round bottom 96 well plate in IMDM media supplemented with 10% FBS, 100 U/ml pencillin, 100 U/ml streptomycin, IL-2 (20 ng/ml) and IL-7 (10 ng/ml). Human tonsillar lymphocytes (2×106) were plated in 200 l RPMI media supplemented with 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, non-essential amino acids, sodium pyruvate, IL-2 (20 ng/ml), IL-7 (10 ng/ml) and IL-1 (20 ng/ml). For initial lethal toxin experiments splenocytes/tonsillar lymphocytes were cultured in media containing in 0.1% serum to minimize the effect of serum on lethal factor enzyme activity. After the initial period of lethal toxin treatment (3 hrs), serum was replenished to a full concentration of 10%. Cells after toxin treatment were stimulated with recombinant mouse or human IL-23 (50 ng/ml) (eBioscience) for 18 hrs. Cell supernatants were harvested by centrifugation at 1,500 rpm for 5 minutes and then used for the measurement of IL-22.

    In vitro lethal toxin assay with MNK-3 cells:

    MNK-3 cells (an ILC3 cell line) were cultured in MNK-3 media (DMEM (High glucose), 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, 2 mM Glutagro, 1 mM sodium pyruvate, 10 mM HEPES, 55 M -mercaptoethanol, 5 g/ml gentamicin, 10 ng/ml IL-7 and 10 ng/ml IL-15). For lethal toxin experiments MNK-3 cells were cultured in media containing 10 ng/ml IL-7. Cells were treated with lethal toxin for 2 hrs followed by IL-23 stimulation for 6 hrs. Cell lysates were analyzed for RNA and supernatants were analyzed for secreted IL-22 by ELISA.

    Lethal Toxin (LT) = PA + LF

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

    Author did not specify which Lethal Factor (LF) was utilized; List Labs provides the following LF:

    Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis
    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

Effect of endosomal acidification on small ion transport through the anthrax toxin PA63 channel

Kalu, N;Alcaraz, A;Yamini, G;Momben Abolfath, S;Lucas, L;Kenney, C;Aguilella, VM;Nestorovich, EM;

Product: Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation

Ouyang, W;Guo, P;Fang, H;Frucht, DM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine

Phaswana, PH;Ndumnego, OC;Koehler, SM;Beyer, W;Crafford, JE;van Heerden, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients

Dumas, EK;Gross, T;Larabee, J;Pate, L;Cuthbertson, H;Charlton, S;Hallis, B;Engler, RJM;Collins, LC;Spooner, CE;Chen, H;Ballard, J;James, JA;Farris, AD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
    of List Biological Laboratories, Inc.
    The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
    antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
    96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
    Bovine plasma (cat # 7310806) was purchased from Lampire Biological Laboratories.

    Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
    based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
    20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
    plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine plasma and not
    diluted.

    LF Activity Assays:

    Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
    (Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
    concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
    all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
    by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
    368 nm and emission to 452 nm with a cutoff filter at 435 nm.

    HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
    a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
    with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
    liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
    300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
    then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
    proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
    reaction mixture was removed from replicate wells and placed in HPLC sample vials.

    HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
    column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
    solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
    25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
    and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
    with excitation set to 350 nm and emission at 450 nm to detect the free coumarin fluorophore cleaved from
    MAPKKide® Plus. The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time
    was 4.8 minutes.

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
    Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
    of List Biological Laboratories, Inc.
    The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
    antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
    96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
    Bovine plasma (cat # 7310806) and sheep plasma (cat# 7319006) were purchased from Lampire Biological
    Laboratories. The milk (2% Lucerne) came from the local market.

    Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
    based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
    20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
    plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine, sheep plasma or
    2% milk without dilution.

    LF Activity Assays:
    Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
    (Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
    concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
    all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
    by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
    368 nm and emission to 452 nm with a cutoff filter at 435 nm.

    HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
    a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
    with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
    liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
    300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
    then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
    proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
    reaction mixture was removed from replicate wells and placed in HPLC sample vials.

    HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
    column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
    solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
    25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
    and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
    with excitation set to 350 nm and emission at 450 nm to detect the free fluorophore cleaved from MAPKKide® Plus.
    The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time was 4.8 minutes.

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
    Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

CAN WE ACHIEVE EFFECTIVE ORAL DELIVERY OF VACCINES? EVALUATING A NEW MICROSPHERE BASED CONTROLLED-RELEASE DELIVERY SYSTEM

Mohanraj, SM;Kende, M;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions

Koehler, SM;Buyuk, F;Celebi, O;Demiraslan, H;Doganay, M;Sahin, M;Moehring, J;Ndumnego, OC;Otlu, S;van Heerden, H;Beyer, W;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis